Page 31 - MaSzeSz hírcsatorna 2016/5-6.
P. 31

SZAKMAI - TUDOMÁNYOS ROVAT












            9. Irodalomjegyzék


            AHEL, M., JELICIC, I., 2001. Phenazone anal- POSEIDON, 2006. Detailed report related
            gesics in soil and groundwater below a mu- to the overall duration (1.1.2001-30.6.2004).
            nicipal solid waste landfill. In: Daughton, C.G.,  Contract No. EVK1-CT-2000-00047
            Jones-Lepp, T. (eds.), Pharmaceuticals and  ROBERTS, P.H., THOMAS, K.V., 2006. The
            Personal Care Products in the Environment:  occurrence of selected pharmaceuticals in
            Scientific and Regulatory Issues. Symposium  wastewater effluent and surface waters of the
            Series 791, American Chemical Society, Wa- lower Tyne catchment. Science of the Total
            shington DC, pp. 100–115.                        Environment 356:143-153
            BUSER, H.R., POIGER, T., MÜLLER, M.D.,  SILVA, E., RAJAPAKSE, N., KORTENKAMP, A.,
            1998b. Occurrence and fate of the pharma- 2002. Something from „nothing” deight weak
            ceutical drug diclofenac in surface waters: ra- estrogenic chemicals combined at concent-
            pid photodegradation in a lake. Environmen- rations below NOECs produce significant
            tal Science and Technolgy 32: 3449–3456.         mixture effects. Environmental Science and
            FENT, K., WESTON, A.A., CAMINADA, D.,  Technology 36: 1751–1756.
            2006. Ecotoxicology of human pharmaceu- TERNES, T. A., STUMOF, M., MUELLER, J., HA-
            ticals. Aquatic Toxicology 76: 122-159.          BERER, K., WILKEN, R.-D., SERVOS, M., 1999.
            GRÖNING, J., HELD, C., GARTEN, C., CLAUSS- Behavior and occurrence of estrogens inmu-
            NITZER, U., KASCHABEK, S.R., SCHLÖMANN,  nicipal sewage treatment plants I. Investiga-
            M., 2007. Transformation of diclofenac by the  tions in Germany, Canada and  Brazil. ScIence
            indigenous microflora of river sediments and  of the Total Environment 225: 81–90.
            identification of a major intermediate. Che-
            mosphere 69: 509-516.
            KRAIGHER, B., KOSJEK, T., HEATH, E., KOM-
            PARE, B., MULEC, I.M., 2008. Influence of
            pharmaceutical residues on the structure of
            activated sludge bacterial communities in wa-
            stewater treatment bioreactors. Water Resear-
            ch 42: 4578-4588.
            KÜMMERER, K., HELMERS, E., 1997. Hospital
            effluents as a source for platinum in the en-
            vironment. Science of the Total Environment
            193: 179–184.
            KÜMMERER, K., 2009. The presence of phar-
            maceuticals in the environment due to hu-
            man use – present knowledge and future
            challenges. Journal of Environmental Mana-
            gement 90: 2354-2366.
            MAGAROU, P., 1999. Urban wastewater in
            Europe: what about sludge. In Proceeding of
            Workshop Problems Around Sludge, Stressa,
            Italy

                                                                                                           31
   26   27   28   29   30   31   32   33   34   35   36